why choose us

Clinical Trials Search

Showing 5,290 of 132,656 result(s)
Survey on Sexual and Gender in the Healthcare in Taiwan

Status: COMPLETED

Condition: Sexual Harassment

Interventions: Without Intervention

Date: 2024-03-28

A Study of LY3841136 in Overweight and Obese Participants

Status: COMPLETED

Condition: Obesity

Interventions: Administered SC.

Date: 2024-03-28

Impact of Probiotics on Children With ADHD

Status: COMPLETED

Condition: Attention Deficit Hyperactivity Disorder

Interventions: The experimental phase of the study had last 56 days, and each patient will make 3 visits (d0, d28, d56).

Date: 2024-03-28

Study on the Chromatic Perception of Digital Systems in Aesthetic Field

Status: COMPLETED

Condition: Color Detection of Upper Central Incisors

Interventions: The patient will under go three different color detecting methods.
Two photography methodologies and one intra oral digital scanner

Date: 2024-03-28

A Clinical Trial of TQB3006 Tablets in Patients With Advanced Malignant Cancer

Status: COMPLETED

Condition: Advanced Malignant Neoplasm

Interventions: TQB3006 is an inhibitor protein.

Date: 2024-03-28

A Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of VX-407 in Healthy Participants

Status: COMPLETED

Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Interventions: Solution or Suspension for oral administration.

Date: 2024-03-28

Training Adaptations With and Without Ventilatory Training Device

Status: COMPLETED

Condition: Healthy

Interventions: Those in the intervention group will wear the respiratory training device for 3 days per week of high-intensity functional training over 6-weeks.

Date: 2024-03-27

Resin Polymer (NuSmile BioFlx) Compared to Stainless Steel Crowns (3M ESPE) for Restoration of Primary Molar Teeth

Status: COMPLETED

Condition: Dental Caries

Interventions: Resin polymer (NuSmile Bioflx)crown

Date: 2024-03-27

A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension

Status: COMPLETED

Condition: Uncontrolled Hypertension

Interventions:

Baxdrostat tablet administered orally, once daily (QD).
Unit dose strength:

  • 1 mg per tablet for 1mg baxdrostat Arm
  • 2 mg per

    Date: 2024-03-27